Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Amplify ETFs Declares February Income Distributions for its ETFs
-
Good Supply Launches New ‘Juiced’ Cannabis Pre-Roll Multi-Packs Across Canada
-
Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
-
Malibu Boats, Inc. to Participate at the Raymond James 2024 Institutional Investors Conference
-
Company Generates Record Subscriptions Sales for 2023 Holiday Season
-
Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial
-
Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference
-
New Look Chooses Dayforce to Transform HR and Payroll
-
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
-
Monaghan Medical Corporation Attains ISO 14001 Certification for Environmental Management Excellence
-
Axsome Therapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
-
Gen II Fund Services Expands Leadership Team with Five New Principal Promotions
-
Michael J. Graff of Air Liquide Announced as Vice Chair of AIChE Foundation
-
ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
-
Generation Bio to Present at the 2024 TD Cowen Health Care Conference
-
Newcore Gold Announces Addition of Omanpe Prospecting License and Completion of an Updated Environmental and Social Baseline Study at the Enchi Gold Project, Ghana
-
Form 8.3 - [WINCANTON PLC - 26 02 2024] - (CGAML)
-
AutoZone 2nd Quarter Total Company Same Store Sales Increase 1.5%; Domestic Same Store Sales Increase 0.3%; EPS Increases to $28.89
-
Asensus Surgical Celebrates 1,000 Senhance Cases Completed at Three Global Hospitals
-
Banle Energy International Limited Arranges Bunkering Services for BYD Explorer No. 1 at the Port of Antwerp
-
Form 8.3 - [SAIETTA GROUP PLC - 26 02 2024] - (CGAML)
-
Form 8.3 - Mondi plc
-
AMPL INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Amplitude, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case
-
Ocwen Financial Announces Full Year and Fourth Quarter 2023 Results
-
Form 8.3 - [ LXi REIT PLC - 26 02 2024] - (CGWL)
-
Olaplex Holdings, Inc. Announces Participation in the Raymond James 45th Annual Institutional Investors Conference on March 5th
-
DSV, 1093 - SHARE BUYBACK IN DSV A/S
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Wincanton plc
-
Synaptics Announces Chief Financial Officer Transition
-
Lavras Gold Corp. Chosen to Exhibit at PDAC Core Shack, March 3-4, Booth #3101A & Investors Exchange Booth 2831
-
Lilium releases Full Year and Fourth Quarter 2023 Shareholder Letter
-
Syntec Optics (Nasdaq: OPTX) Enabling Optics for Blindness
-
Hut 8 Commences Construction of New Digital Asset Mining Site in Culberson County, Announces New Treasury Strategy
-
Beam Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Reiterates Anticipated Milestones
-
Lavras Gold Corp. Chosen to Exhibit at PDAC Core Shack, March 3-4, Booth #3101A & Investors Exchange Booth 2831
-
SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Updates
-
Update on offer for subscription
-
Fingrid’s Financial Statements Bulletin January–December 2023: Clean and high-quality electricity system and largest ever grid investments created conditions for electricity consumption growth
-
Borregaard ASA: Reporting of transactions in Borregaard ASA's shares made by person discharging managerial responsibilities
-
Notice convening the NKT Annual General Meeting
-
GABO Mining Ltd Announces $1,000,000 Private Placement
-
Hesai Group to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 11, 2024
-
Standard Uranium Begins Drilling at Atlantic Project, Eastern Athabasca Basin
-
HighPeak Energy, Inc. Announces 2023 Fourth Quarter and Yearend Earnings Release and Conference Call Dates
-
Tarsus Reports Strong Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Achievements
-
Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries
-
Esperion Reports Fourth Quarter and Full Year 2023 Financial Results
-
Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results
-
Zymeworks Announces Participation in Upcoming Investor Conferences
-
AirSculpt Technologies Reports Double Digit Revenue Growth for the Fourth Quarter and Full Year 2023
